Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xin Nao Jing Tablet
- Development stage
- Unknown
- Lead developer
- Jinsheng Da Ren Tang
- Administration
- Oral
01
Overview
Xin Nao Jing Tablet (also known as Xin Nao Jing Pian) is an approved traditional Chinese medicine (TCM) developed and manufactured by Jinsheng Da Ren Tang (Tianjin Pharmaceutical Da Ren Tang Group). It is formulated as an oral tablet containing a mixture of 16 traditional ingredients, including Plumula Nelumbinis, Margaritifera Concha, Sophorae Flos, Phellodendri Chinensis Cortex, Aucklandiae Radix, Scutellariae Radix, Prunellae Spica, Uncaria Ramulus Cum Uncis, Gentianae Radix Et Rhizoma, Lophatheri Herba, Clematidis Radix Et Rhizoma, Arisaematis Rhizoma, Glycyrrhizae Radix Et Rhizoma, Bovis Calculus Artifactus, Cinnabaris, and Borneolum Syntheticum. The formulation is clinically used to calm the liver, suppress yang, clear the heart, and calm the mind. It is primarily indicated for the treatment of vertigo, stroke, and hypertension associated with liver yang hyperactivity syndrome, presenting with symptoms such as dizziness, irritability, slurred speech, and hemiplegia.
- Other names
- Xin Nao Jing PianXin Nao Jing Tablet心脑静片
Beyond the preview
Go deeper on Xin Nao Jing Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xin Nao Jing Tablet.